Is Surgery the Only Fate of the Patient with Leriche Syndrome ? Our Endovascular Therapy Results Early Follow-Up Outcomes
dc.contributor.author | Beyaz, Metin Onur | |
dc.contributor.author | Urfali, Senem | |
dc.contributor.author | Kaya, Sefer | |
dc.contributor.author | Oruc, Dilan | |
dc.contributor.author | Fansa, Iyad | |
dc.date.accessioned | 2024-09-18T21:06:35Z | |
dc.date.available | 2024-09-18T21:06:35Z | |
dc.date.issued | 2022 | |
dc.department | Hatay Mustafa Kemal Üniversitesi | en_US |
dc.description.abstract | Aim: In this research, we aimed to present early follow-up results of the endovascular treatment in patients with Leriche syndrome at our single center.Methods and materials: Between October 2020 and January 2022, 14 patients with Leriche syndrome (12 men, two women) who underwent endovascular treatment at our center retrospectively were evaluated. Before the treatment, the ankle-brachial index (ABI) was found 0.50 +/- 0.11 on the right leg and 0.45 +/- 0.09 on the left leg.Results: All of the patients with Leriche syndrome applied to our clinic for the first time. In five patients, the fully occluded lesion length was over 3 cm (ranging between 3.5-7.2 cm), hence they were treated with aortic and bilat-eral iliac bare metallic stents. Although in one patient, the aortic occluding lesion was below 3 cm; it was treated with a bare aortic and bilateral bare iliac stent application because the lesion in the aorta was too calcific. In eight patients, the lesion length was less than 3 cm, bilateral iliac metal bare stents were applied in a kissing stent way.Conclusion: Endovascular therapy for chronic aorto-iliac occlusive disease has an early high technical success with pri-mary and secondary patency rates. Especially in patients with high risk factors, it may be considered as a good alternative to conventional surgery. | en_US |
dc.identifier.doi | 10.1532/hsf.4691 | |
dc.identifier.endpage | E725 | en_US |
dc.identifier.issn | 1098-3511 | |
dc.identifier.issn | 1522-6662 | |
dc.identifier.issue | 5 | en_US |
dc.identifier.pmid | 36317918 | en_US |
dc.identifier.startpage | E721 | en_US |
dc.identifier.uri | https://doi.org/10.1532/hsf.4691 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12483/13704 | |
dc.identifier.volume | 25 | en_US |
dc.identifier.wos | WOS:000872369700001 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Forum Multimedia Publishing, Llc | en_US |
dc.relation.ispartof | Heart Surgery Forum | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Aortoiliac Occlusive Disease | en_US |
dc.subject | Management | en_US |
dc.subject | Balloon | en_US |
dc.title | Is Surgery the Only Fate of the Patient with Leriche Syndrome ? Our Endovascular Therapy Results Early Follow-Up Outcomes | en_US |
dc.type | Article | en_US |